Ring Therapeutics
Revolutionizing Medicine with Commensal Viruses
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- ringtx.com
- Total Funding
- $203.5M
- Last Round
- $86.5M Series CMar 2023
- Rounds
- 2
About
Ring Therapeutics, founded by Flagship Pioneering in 2017, is developing a novel gene therapy platform based on anelloviruses — commensal human viruses. Programmable, redosable DNA medicines.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.